Knight Therapeutics Inc.: In the Beginning of a Genesys Partnership
MONTREAL, QUEBEC -- (Marketwired) -- 08/16/16 -- Knight Therapeutics Inc. (TSX: GUD) ("Knight"), a leading Canadian specialty pharmaceutical company, announced today that it has committed to invest $1 million in the Genesys Ventures III LP (…